Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
High Park Gardens was the operating name used for the Leamington, Ontario cannabis cultivation and manufacturing business that Tilray acquired through the purchase of Natura Naturals in February 2019. The facility was positioned to supply cannabis products for Canadian adult-use and medical markets, and Tilray described its output as pharmaceutical-grade medical cannabis in company communications. In May 2020, Tilray announced the permanent shutdown of the High Park Gardens facility as part of an optimization plan for its Canadian adult-use operations. As a result, High Park Gardens appears to have been a real operating cannabis subsidiary/facility rather than an independent biotech company, but it is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on High Park Gardens.